News from sanofi canada A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 17, 2018, 07:00 ET Canadians are invited to join the conversation: Raise Your Hand for Diabetes

LAVAL, QC, Oct. 17, 2018 /CNW Telbec/ - Sanofi Canada is on a mission to raise awareness and money to help people living with diabetes, one of the leading causes of death and disability in Canada.1...


Sep 27, 2018, 16:55 ET Canadians living with diabetes in Ontario and Manitoba now have greater access to diabetes medicine

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) * Toujeo® receives provincial formulary coverage in Ontario * Lantus® gains improved provincial formulary coverage in Manitoba LAVAL, QC, Sept. 27, 2018...


Jul 10, 2018, 07:02 ET Sanofi denounces CADTH negative recommendation that could limit treatment options for Canadians with atopic dermatitis

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) * CADTH recommendation for Dupixent™ disregards patient input and ignores clinical value LAVAL, QC, July 10, 2018 /CNW Telbec/ - Sanofi Genzyme is...


Jun 13, 2018, 07:23 ET Canadian employers underestimate the proportion of their workforce with a chronic condition and its impact

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Three-quarters of employers are worried about the impact of unmanaged chronic disease Two-thirds (66%) of Canadian employees would consent to receive...


Jun 08, 2018, 08:00 ET Canadian science prodigy winner of prestigious international competition

Sajeev Kohli, a Grade 11 student from Waterloo, Ontario, receives top honours in the Global Healthcare Challenge LAVAL, QC, June 7, 2018 /CNW Telbec/ - Sajeev Kohli, a grade 11 student science...


May 16, 2018, 07:00 ET Canadians living with diabetes can now access a new resource to help better manage their disease

LAVAL, QC, May 16, 2018 /CNW/ - Sanofi and Sun Life Financial are pleased to announce a new program that provides Canadians living with diabetes access to health information related to the use of...


Apr 12, 2018, 17:20 ET Sanofi to invest €350 million in Canadian vaccine facility

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Expansion demonstrates company's commitment to innovation and leadership in global public health New Toronto facility is one of the largest-ever investments ...


Apr 12, 2018, 08:00 ET New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain healthy blood glucose levels

* Panel of Canadian experts recommend new ways to overcome barriers Canadians face when trying to achieving their target glucose (blood sugar) levels.1 LAVAL, QC, April 12, 2018 /CNW Telbec/ - Faced...


Apr 11, 2018, 07:00 ET /R E P E A T -- Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility/

TORONTO, April 10, 2018 /CNW Telbec/ - Sanofi invites members of the media to the announcement of a landmark investment in lifesaving vaccine production in Canada. The investment will cement the...


Apr 10, 2018, 11:00 ET Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility

TORONTO, April 10, 2018 /CNW Telbec/ - Sanofi invites members of the media to the announcement of a landmark investment in lifesaving vaccine production in Canada. The investment will cement the...


Dec 12, 2017, 13:12 ET The results of a recent study favour Toujeo® over degludec and real-world evidence confirms Toujeo®'s value

Results of studies comparing Sanofi's Toujeo® and insulin degludec Clinical implications for people living with diabetes LAVAL, QC, Dec. 12, 2017 /CNW Telbec/ - Sanofi Canada announces the results of ...


Oct 17, 2017, 14:20 ET Insulin in People Living with Type 2 Diabetes: Initiation and Dosage

Favourable results from a scientific study conducted by Canadian investigators on the dosage adjustment of Toujeo® LAVAL, QC, Oct. 17, 2017 /CNW Telbec/ - Individuals with type 2 diabetes may need...


May 29, 2017, 09:09 ET The 20th Anniversary of The Sanofi Canada Healthcare Survey reveals surprising facts

Employees not as happy with health benefits as past years & are more willing to give access to personal data MONTREAL, May 29, 2017 /CNW Telbec/ - The 20th anniversary of The Sanofi Canada Healthcare ...


May 12, 2017, 12:42 ET Université de Montréal Doctoral Student earns Global Nursing Innovation Award

LAVAL, QC, May 12, 2017 /CNW/ - The Connecting Nurses Patient Centricity program is proud to announce that Guillaume Fontaine, a Montreal-based graduate student and registered nurse, will be a...


May 26, 2016, 16:17 ET U.S.FDA Advisory Committee Recommends Approval of Sanofi Treatment for Adults with Type 2 Diabetes

- FDA decisions on the investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide and investigational lixisenatide anticipated in Q3 2016 - ...


May 24, 2016, 11:02 ET New Cholesterol Treatment Now Available for Canadians

As 8 in 10 Canadian GPs identify the need for new cholesterol treatment options, Canadian Patients now have access to PRALUENT™ MONTREAL, May 24, 2016 /CNW Telbec/ - Sanofi Canada is pleased to...


May 09, 2016, 13:43 ET Canada's Top Student Scientist Recognized at Sanofi Biogenius Canada National Final

Iveta Demirova, 16, student at New Westminster Secondary School in British Columbia, Recognized for Novel HIV-1 Treatment OTTAWA, May 9, 2016 /CNW Telbec/ - Iveta Demirova from New Westminster...


Feb 23, 2016, 16:05 ET Sanofi to Return Allerject® (epinephrine injection, USP) Rights to kaléo

For Canadian media only LAVAL, QC, Feb. 23, 2016 /CNW Telbec/ - Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that the License and Development Agreement between Sanofi and kaléo, formerly...


Dec 02, 2015, 08:00 ET Update by Sanofi Canada on Nationwide Voluntary Recall of Allerject®

For Canadian media only LAVAL, QC, Dec. 2, 2015 /CNW Telbec/ - Following the October 28, 2015 voluntary recall by Sanofi-aventis Canada Inc. (Sanofi Canada) of all lots of Allerject® epinephrine...


Nov 09, 2015, 08:15 ET Shaping Tomorrow's Health: Sanofi Canada Recognized as One of Canada's Top 100 Employers

MONTREAL, Nov. 9, 2015 /CNW Telbec/ - Sanofi Canada is proud to announce that it has been named one of Canada's Top 100 Employers by a prestigious annual competition that recognizes the nation's best ...


Oct 28, 2015, 17:46 ET Sanofi Canada Issues Voluntary Nationwide Recall of Allerject® Due to Potential Inaccurate Dosage Delivery

LAVAL, QC, Oct. 28, 2015 /CNW Telbec/ - Sanofi-aventis Canada Inc. (Sanofi Canada) is recalling all Allerject® (epinephrine injection, USP). The voluntary recall involves all Allerject currently on...


Sep 01, 2015, 10:40 ET Sanofi and Regeneron Announce New Positive Praluent® (alirocumab) Phase 3 Data Presented at ESC Congress 2015

- Largest Phase 3 analysis of patients with familial hypercholesterolemia showed adding Praluent to standard-of-care therapy reduced LDL-cholesterol by an average 56 percent compared to...


Jul 16, 2015, 09:15 ET NeoStrata® and VIFF Celebrate Canadian Talent on the Big Screen

Canadian Skin Care Brand NeoStrata® is the Official Skincare Sponsor of VIFF in Collaboration with London Drugs MONTREAL, July 16, 2015 /CNW Telbec/ - Canadian cosmeceutical brand NeoStrata has...


Jun 16, 2015, 17:37 ET Canadian Student Scientist Wins Prestigious Award at International Competition

Austin Wang, Grade 11 Student from Vancouver, Recognized for Environmental Biotech MONTREAL, June 16, 2015 /CNW Telbec/ - Austin Wang, a grade 11 student at Vancouver's David Thompson Secondary...


Jun 13, 2015, 16:51 ET Voluntary Product Recall: 2 Lots of Allerject 0.15 mg / 0.15 mL epinephrine injection, distributed as of June 1, 2015

MONTREAL, June 13, 2015 /CNW Telbec/ - Sanofi-aventis Canada Inc. (Sanofi Canada) is taking the precautionary measure of issuing a Voluntary Recall of Allerject 0.15 mg / 0.15 mL epinephrine auto...